An Insight Into the Modulatory Effects and Mechanisms of Action of Phyllanthus Species and Their Bioactive Metabolites on the Immune System
- PMID: 31440162
- PMCID: PMC6693410
- DOI: 10.3389/fphar.2019.00878
An Insight Into the Modulatory Effects and Mechanisms of Action of Phyllanthus Species and Their Bioactive Metabolites on the Immune System
Abstract
Phyllanthus species (family; Euphorbiaceae) have been intensively studied for their immunomodulating effects due to their wide-ranging uses to treat immune-related diseases in indigenous medicine, which are primarily lack of scientific basis. The focuses of this review are on the significance of Phyllanthus species and their bioactive metabolites particularly corilagin (1), geraniin (2), gallic acid (3), phyllanthin (4), hypophyllanthin (5), ellagic acid (6), phyltetralin (7), niranthin (8), catechin (9), quercetin (10), astragalin (11), and chebulagic acid (12) in the modulation of both innate and adaptive immune systems through various mechanisms and their possible therapeutic benefits for treatment of immune-related diseases. We have compiled all significant findings published in the literature, and the data were analyzed critically to provide perspectives and directions for future research for the plants as a prospective source of novel immunomodulating agents. Various Phyllanthus species particularly Phyllanthus amarus, Phyllanthus emblica, Phyllanthus niruri, and Phyllanthus urinaria have been documented to possess significant immunomodulatory effects. However, the possible challenges encountered by the application of extracts of various Phyllanthus species and their bioactive constituents as immunomodulators need to be addressed. Most reports on the biological and pharmacological studies of the plants were based on crude extracts. The extracts were not chemically characterized, and the contributions of their chemical constituents to the bioactivities were not identified. The underlying mechanisms involved in the immunomodulatory effects of the Phyllanthus species were not indepthly studied due to limitations in terms of design, conduct, and interpretation. Extensive experimental and preclinical studies on the immunomodulating potential of Phyllanthus species should be carried out to provide sufficient data to prove that their traditional uses are inherently effective and safe and will allow clinical trials to be pursued for their further development as therapeutic agents to treat immune-related disorders.
Keywords: Phyllanthus species; ethnomedicine; immunomodulators; immunosuppressive effects; phytochemicals.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6693410/bin/fphar-10-00878-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6693410/bin/fphar-10-00878-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6693410/bin/fphar-10-00878-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6693410/bin/fphar-10-00878-g004.gif)
Similar articles
-
Modulation of cell signaling pathways by Phyllanthus amarus and its major constituents: potential role in the prevention and treatment of inflammation and cancer.Inflammopharmacology. 2020 Feb;28(1):1-18. doi: 10.1007/s10787-019-00671-9. Epub 2019 Dec 2. Inflammopharmacology. 2020. PMID: 31792765 Review.
-
Phytochemical profile and hepatoprotective potentiality of Phyllanthus genus: a review.J Pharm Pharmacol. 2024 Apr 20:rgae040. doi: 10.1093/jpp/rgae040. Online ahead of print. J Pharm Pharmacol. 2024. PMID: 38642916
-
Lignans and Polyphenols of Phyllanthus amarus Schumach and Thonn Induce Apoptosis in HCT116 Human Colon Cancer Cells through Caspases-Dependent Pathway.Curr Pharm Biotechnol. 2021;22(2):262-273. doi: 10.2174/1389201021666200612173029. Curr Pharm Biotechnol. 2021. PMID: 32532192
-
Inhibitory effects of compounds from Phyllanthus amarus on nitric oxide production, lymphocyte proliferation, and cytokine release from phagocytes.Drug Des Devel Ther. 2016 Jun 9;10:1935-45. doi: 10.2147/DDDT.S105651. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27354767 Free PMC article.
-
Immunomodulatory Effects and Mechanisms of Curcuma Species and Their Bioactive Compounds: A Review.Front Pharmacol. 2021 Apr 30;12:643119. doi: 10.3389/fphar.2021.643119. eCollection 2021. Front Pharmacol. 2021. PMID: 33995049 Free PMC article. Review.
Cited by
-
Acute and Subchronic Toxicological Study of the Cocktail Extract from Curcuma xanthorrhiza Roxb, Phyllanthus niruri L. and Morinda citrifolia L.J Toxicol. 2024 Mar 27;2024:9445226. doi: 10.1155/2024/9445226. eCollection 2024. J Toxicol. 2024. PMID: 38571743 Free PMC article.
-
Debittering of Emblica (Phyllanthus emblica L.) fruit powder: Preparation and biological activity.Food Chem X. 2024 Jan 2;21:100853. doi: 10.1016/j.fochx.2023.100853. eCollection 2024 Mar 30. Food Chem X. 2024. PMID: 38282828 Free PMC article.
-
Potential Immunoregulatory Mechanism of Plant Saponins: A Review.Molecules. 2023 Dec 23;29(1):113. doi: 10.3390/molecules29010113. Molecules. 2023. PMID: 38202696 Free PMC article. Review.
-
Immunomodulatory Effect of a Polyherbal Formulation (Imusil) on Cyclophosphamide Induced Experimental Animal Model.Asian Pac J Cancer Prev. 2023 Nov 1;24(11):3729-3738. doi: 10.31557/APJCP.2023.24.11.3729. Asian Pac J Cancer Prev. 2023. PMID: 38019230 Free PMC article.
-
Phyllanthus emblica: a comprehensive review of its phytochemical composition and pharmacological properties.Front Pharmacol. 2023 Oct 26;14:1288618. doi: 10.3389/fphar.2023.1288618. eCollection 2023. Front Pharmacol. 2023. PMID: 37954853 Free PMC article. Review.
References
-
- Ademokun A. A., Dunn-Walters D. (2001). Immune responses: primary and secondary. In e LS. (Chichester: John Wiley & Sons Ltd; ). 10.1002/9780470015902.a0000947.pub2 - DOI
-
- Akhter S., Simom Hasan M., Hasan M., Begum Y. (2018). Investigation of in vivo analgesic and anti-inflammatory activities of methanol extracts of Phyllanthus reticulatus and Mimosa pigra . J. Pharmacog. Phytochem. 7, 2378–2385.
Publication types
LinkOut - more resources
Full Text Sources